Skip to content

A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japan

A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japan - Validity of modified treatment strategy for neonatal jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021057
Enrollment
6000
Registered
2016-04-01
Start date
2015-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundice

Interventions

None listed

Sponsors

Kobe University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: newborns treated for neonatal jaundice during study period

Exclusion criteria

Exclusion criteria: patients without consent from parents

Design outcomes

Primary

MeasureTime frame
The rate of kernicterus and neurodevelopmental mobidity at 18 months corrected age

Secondary

MeasureTime frame
The duration of phototherapy and the rate of exchange transfusion

Countries

Japan

Contacts

Public ContactIchiro Morioka

Kobe University Department of pediatrics

ichim@med.kobe-u.ac.jp81-78-382-6090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026